Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: Phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6 × FEC versus 3 × FEC/3 × Docetaxel

Figure 2

Risk assessment using the clinical and pathological algorithm (CP) adopted from St. Gallen and NPI. - all patients G1 or G2 <2 cm were assessed as low-risk if no additional risk factors were present. Patients showing an additional risk factor or G2tumors ≥2 cm or G3 were assessed high-risk.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us